Sponsored by Johnson & Johnson Medical Affairs
Quality of Vision with the TECNIS PureSee™ IOL Elevates Extended Depth-of-Focus IOLs
Since the first extended depth-of-focus (EDOF) intraocular lens (IOL) entered the U.S. market a decade ago, surgeons have balanced patients’ desire for better near vision against the potential tradeoff in quality of distance vision. Patients and doctors alike found it unacceptable for visual acuity at distance to fall short of results offered by monofocal IOLs and specifically monovision, thus limiting the use of EDOF IOLs.
That tradeoff has changed with the introduction of the TECNIS PureSee™ IOL (Johnson & Johnson), an EDOF lens that is fundamentally different from previous technologies. TECNIS PureSee™ has a purely refractive design. The continuous change in power on the posterior surface of the IOL has no sharp or abrupt changes in elevations, edges, or steps, thus reducing the chances of visual symptoms such as glare, halos, and starbursts, just like a monofocal. This unique design makes the TECNIS PureSee™ IOL a lens with monofocal-like quality distance that minimizes the loss of contrast sensitivity just like a monofocal lens.
EDOF without tradeoffs
The FDA clinical study of the TECNIS PureSee™ IOL was a prospective, multicenter, randomized, bilateral implant clinical study that took place at nine U.S. sites over six months. Patients were implanted with either the TECNIS PureSee™ EDOF IOL (n = 113) or the monofocal control, TECNIS™ DCB00 (n = 110). Key study endpoints were visual acuity, mesopic contrast sensitivity, visual symptoms, and patient satisfaction1:
Binocular visual acuity. The TECNIS PureSee™ IOL provided improved intermediate and near visual acuity, while maintaining comparable distance visual acuity compared to the aspheric monofocal IOL (Figure 1). In addition, monocular distance vision was not significantly different than the monofocal IOL.
Mesopic contrast sensitivity. The TECNIS PureSee™ IOL maintained contrast sensitivity at the level of the monofocal IOL for all spatial frequencies, independent of pupil size.
Visual symptoms at six months. Rates of halos and starbursts were identical for both lens groups (2.7%).1 The TECNIS PureSee™ IOL group fared slightly better than the aspheric monofocal IOL group with glare (2.7% vs. 5.5%, respectively).1
Patient satisfaction. About 97% of patients said they would recommend the TECNIS PureSee™ IOL to friends or family, which, as expected, was dramatically higher than the monofocal IOL.2
Results for the TECNIS PureSee™ IOL were different from previous EDOF lenses, with improved intermediate visual acuity and distance visual acuity comparable to an aspheric monofocal IOL. As the first and only FDA-approved EDOF IOL with no loss of contrast sensitivity comparable to a monofocal, the TECNIS PureSee™ IOL is also the first EDOF with no FDA warnings on contrast. The improved contrast sensitivity enhances quality of vision under difficult circumstances such as night driving.
While the data presented here represented targeting for emmetropia OU from the FDA study protocol, in my practice for my patients, I target the first minus for PureSee in the dominant eye as long as the first minus is no more than -0.25. In the non-dominant eye, I target first or second minus depending upon the patient’s request, for those who desire mini monovision offset by -0.75. Using these targets, I maintain excellent distance vision and maximize the near vision. With low risk of dysphotopsias and no sacrificing distance vision for better reading, the TECNIS PureSee™ IOL makes EDOF a high-quality option for many patients.
A game-changer for surgeons
This comparative study showed that the TECNIS PureSee™ IOL significantly advances patients’ quality of vision by delivering high binocular visual acuity and contrast sensitivity with a low rate of visual symptoms. It is a promising lens that opens up the EDOF option to a larger pool of presbyopic patients. In my clinical experience, I’ve even had success with patients I previously did not consider multifocal candidates because they had prior LASIK or mild epiretinal membranes.

In my opinion, the TECNIS PureSee™ IOL’s performance with distance vision and contrast sensitivity also resolves a conflict that many surgeons experience. Some doctors who want to improve near vision for presbyopic patients have stopped using multifocal lenses because patients were sometimes unhappy with their distance vision. The tolerability built into the TECNIS™ platform enables more patients to achieve an excellent result with the TECNIS PureSee™ IOL, even when there is some residual sphere or cylinder. The larger landing zone makes it very easy to get the result that patients want, and LASIK enhancement rates are low. In summary, the TECNIS PureSee™ EDOF IOL is a refractive IOL that’s well suited even to non-refractive surgeons, which will expand the use of this unique presbyopic IOL.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- A New Era of Advanced IOLs
A Head-to-Head Study of Two Full Visual Range Lens Platforms
Matthew Hirabayashi, MDMatthew Hirabayashi, MD - A New Era of Advanced IOLs
How Do Different IOL Categories Tolerate Residual Astigmatism?
Karolinne Rocha, MD, PhDKarolinne Rocha, MD, PhD
